Cannapharmarx, Inc. (CPMD)
CPMD is quoted over the counter, not listed on an exchange. Cannapharmarx, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | CPMD, quoted over the counter |
| SEC CIK | 0001081938 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Pharmaceutical Preparations |
| Business address | Mountain View County |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "Accordingly, there is substantial doubt about the Company's ability to continue as a going concern." | 10-Q 2026-08-18 |
| Cash and burn | $555 cash; operating cash flow -$28K a quarter. | Report 2026-06-30 |
| Shares outstanding | 708,689,905 (2026-08-18); 662,501,405 a year earlier; 298,987,175 three years earlier. | Cover page 2026-08-18 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Barzily&Co Certified Public Accountants, Jerusalem, Israel; changed auditors 2 times in 24 months | 8-K 4.01 2024-12-03 |
| Late filings, 12 months | 2 NT notices | NT 10-Q 2026-08-17 |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $276K | -$1.9M | -$127K | $555 | $14.9M | $1.7M | 10-Q 2026-08-18 |
| Q1 2026 2026-03-31 | $627K | -$382K | -$244K | $633 | $1.5M | $1.7M | 10-Q 2026-05-20 |
| Q4 2025 2025-12-31 | $139K | -$7.5M | $1.1M | $2K | $15.6M | $1.4M | 10-K 2026-03-31 |
| Q3 2025 2025-09-30 | $657K | -$1.5M | -$803K | $927 | $2.0M | $1.7M | 10-Q 2025-11-14 |
| Q2 2025 2025-06-30 | $232K | -$1.4M | -$446K | $17K | $4.7M | $1.4M | 10-Q 2026-08-18 |
| Q1 2025 2025-03-31 | $335K | -$691K | -$601K | $1K | $1.8M | $1.1M | 10-Q 2026-05-20 |
| Q4 2024 2024-12-31 | $482K | -$3.7M | -$180K | $2K | $15.1M | $820K | 10-K 2026-03-31 |
| Q3 2024 2024-09-30 | $312K | $188K | -$541K | $7K | $8.0M | $338K | 10-Q 2025-11-14 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2022-08-11 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-18 |
| Latest current report | 8-K | 2026-01-13 |
| Latest proxy | DEF 14A | 2022-10-04 |
Source: SEC EDGAR submissions feed, 365 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier